This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alcami, A. Articles by Smith, G. L. Search for Related Content PubMed PubMed Citation Articles by Alcami, A. Articles by Smith, G. L.

 Previous Article  |  Next Article 

J. Virol., Aug 1995, 4633-4639, Vol 69, No. 8
Copyright © 1995, American Society for Microbiology

Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity

A Alcami and GL Smith
Sir William Dunn School of Pathology, University of Oxford, United Kingdom.

Soluble receptors for gamma interferon (IFN-gamma) are secreted from cells infected by 17 orthopoxviruses, including vaccinia, cowpox, rabbitpox, buffalopox, elephantpox, and camelpox viruses, representing three species (vaccinia, cowpox, and campelpox viruses). The B8R open reading frame of vaccinia virus strain Western Reserve, which has sequence similarity to the extracellular binding domain of cellular IFN- gamma receptors (IFN-gamma Rs), is shown to encode an IFN-gamma binding activity by expression in recombinant baculovirus. The soluble virus IFN-gamma Rs bind IFN-gamma and, by preventing its interaction with the cellular receptor, interfere with the antiviral effects induced by this cytokine. Interestingly, in contrast to cellular IFN-gamma Rs, which are highly species specific, the vaccinia, cowpox, and camelpox virus IFN-gamma Rs bind and inhibit the biological activity of human, bovine, and rat IFN-gamma but not mouse IFN-gamma. This unique broad species specificity of the IFN-gamma R would aid virus replication in different species and suggests that vaccinia, cowpox, and camelpox viruses may have evolved in several species, possibly including humans but excluding mice. Last, the conservation of an IFN-gamma R in orthopoxviruses emphasizes the importance of IFN-gamma in defense against poxvirus infections.

This article has been cited by other articles:

• Davis, A. M., Hagan, K. A., Matthews, L. A., Bajwa, G., Gill, M. A., Gale, M. Jr., Farrar, J. D. (2008). Blockade of Virus Infection by Human CD4+ T Cells via a Cytokine Relay Network. J. Immunol. 180: 6923-6932 [Abstract] [Full Text]  
• Xu, R.-H., Cohen, M., Tang, Y., Lazear, E., Whitbeck, J. C., Eisenberg, R. J., Cohen, G. H., Sigal, L. J. (2008). The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination. J. Exp. Med. 205: 981-992 [Abstract] [Full Text]  
• Nuara, A. A., Walter, L. J., Logsdon, N. J., Yoon, S. I., Jones, B. C., Schriewer, J. M., Buller, R. M., Walter, M. R. (2008). Structure and mechanism of IFN-{gamma} antagonism by an orthopoxvirus IFN-{gamma}-binding protein. Proc. Natl. Acad. Sci. USA 105: 1861-1866 [Abstract] [Full Text]  
• Randall, R. E., Goodbourn, S. (2008). Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89: 1-47 [Abstract] [Full Text]  
• Waibler, Z., Anzaghe, M., Ludwig, H., Akira, S., Weiss, S., Sutter, G., Kalinke, U. (2007). Modified Vaccinia Virus Ankara Induces Toll-Like Receptor-Independent Type I Interferon Responses. J. Virol. 81: 12102-12110 [Abstract] [Full Text]  
• Garcel, A., Crance, J.-M., Drillien, R., Garin, D., Favier, A.-L. (2007). Genomic sequence of a clonal isolate of the vaccinia virus Lister strain employed for smallpox vaccination in France and its comparison to other orthopoxviruses. J. Gen. Virol. 88: 1906-1916 [Abstract] [Full Text]  
• Huang, J., Smirnov, S. V., Lewis-Antes, A., Balan, M., Li, W., Tang, S., Silke, G. V., Putz, M. M., Smith, G. L., Kotenko, S. V. (2007). Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc. Natl. Acad. Sci. USA 104: 9822-9827 [Abstract] [Full Text]  
• Ahmed, C. M., Martin, J. P., Johnson, H. M. (2007). IFN Mimetic as a Therapeutic for Lethal Vaccinia Virus Infection: Possible Effects on Innate and Adaptive Immune Responses. J. Immunol. 178: 4576-4583 [Abstract] [Full Text]  
• Nuara, A. A., Buller, R. M. L., Bai, H. (2007). Identification of residues in the ectromelia virus gamma interferon-binding protein involved in expanded species specificity. J. Gen. Virol. 88: 51-60 [Abstract] [Full Text]  
• Garcia, M. A., Gil, J., Ventoso, I., Guerra, S., Domingo, E., Rivas, C., Esteban, M. (2006). Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative Action. Microbiol. Mol. Biol. Rev. 70: 1032-1060 [Abstract] [Full Text]  
• Yang, C.-Y., Kuo, T.-H., Ting, L.-P. (2006). Human Hepatitis B Viral e Antigen Interacts with Cellular Interleukin-1 Receptor Accessory Protein and Triggers Interleukin-1 Response. J. Biol. Chem. 281: 34525-34536 [Abstract] [Full Text]  
• Nuara, A. A., Bai, H., Chen, N., Buller, R. M. L., Walter, M. R. (2006). The Unique C Termini of Orthopoxvirus Gamma Interferon Binding Proteins Are Essential for Ligand Binding. J. Virol. 80: 10675-10682 [Abstract] [Full Text]  
• Mujtaba, M. G., Patel, C. B., Patel, R. A., Flowers, L. O., Burkhart, M. A., Waiboci, L. W., Martin, J., Haider, M. I., Ahmed, C. M., Johnson, H. M. (2006). The Gamma Interferon (IFN-{gamma}) Mimetic Peptide IFN-{gamma}(95-133) Prevents Encephalomyocarditis Virus Infection both in Tissue Culture and in Mice.. CVI 13: 944-952 [Abstract] [Full Text]  
• Beard, P. M., Froggatt, G. C., Smith, G. L. (2006). Vaccinia virus kelch protein A55 is a 64 kDa intracellular factor that affects virus-induced cytopathic effect and the outcome of infection in a murine intradermal model. J. Gen. Virol. 87: 1521-1529 [Abstract] [Full Text]  
• Najarro, P., Gubser, C., Hollinshead, M., Fox, J., Pease, J., Smith, G. L. (2006). Yaba-like disease virus chemokine receptor 7L, a CCR8 orthologue.. J. Gen. Virol. 87: 809-816 [Abstract] [Full Text]  
• Esteban, D. J., Buller, R. M. L. (2005). Ectromelia virus: the causative agent of mousepox. J. Gen. Virol. 86: 2645-2659 [Abstract] [Full Text]  
• Bartlett, N. W., Buttigieg, K., Kotenko, S. V., Smith, G. L. (2005). Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J. Gen. Virol. 86: 1589-1596 [Abstract] [Full Text]  
• Jackson, S. S., Ilyinskii, P., Philippon, V., Gritz, L., Yafal, A. G., Zinnack, K., Beaudry, K. R., Manson, K. H., Lifton, M. A., Kuroda, M. J., Letvin, N. L., Mazzara, G. P., Panicali, D. L. (2005). Role of Genes That Modulate Host Immune Responses in the Immunogenicity and Pathogenicity of Vaccinia Virus. J. Virol. 79: 6554-6559 [Abstract] [Full Text]  
• Whitmire, J. K., Tan, J. T., Whitton, J. L. (2005). Interferon-{gamma} acts directly on CD8+ T cells to increase their abundance during virus infection. J. Exp. Med. 201: 1053-1059 [Abstract] [Full Text]  
• McCurdy, L. H., Rutigliano, J. A., Johnson, T. R., Chen, M., Graham, B. S. (2004). Modified Vaccinia Virus Ankara Immunization Protects against Lethal Challenge with Recombinant Vaccinia Virus Expressing Murine Interleukin-4. J. Virol. 78: 12471-12479 [Abstract] [Full Text]  
• Bartlett, N. W., Dumoutier, L., Renauld, J.-C., Kotenko, S. V., McVey, C. E., Lee, H.-J., Smith, G. L. (2004). A new member of the interleukin 10-related cytokine family encoded by a poxvirus. J. Gen. Virol. 85: 1401-1412 [Abstract] [Full Text]  
• Nathaniel, R., MacNeill, A. L., Wang, Y.-X., Turner, P. C., Moyer, R. W. (2004). Cowpox virus CrmA, Myxoma virus SERP2 and baculovirus P35 are not functionally interchangeable caspase inhibitors in poxvirus infections. J. Gen. Virol. 85: 1267-1278 [Abstract] [Full Text]  
• Esteban, D. J., Nuara, A. A., Buller, R. M. L. (2004). Interleukin-18 and glycosaminoglycan binding by a protein encoded by Variola virus. J. Gen. Virol. 85: 1291-1299 [Abstract] [Full Text]  
• Legrand, F. A., Verardi, P. H., Jones, L. A., Chan, K. S., Peng, Y., Yilma, T. D. (2004). Induction of Potent Humoral and Cell-Mediated Immune Responses by Attenuated Vaccinia Virus Vectors with Deleted Serpin Genes. J. Virol. 78: 2770-2779 [Abstract] [Full Text]  
• Seet, B. T., McCaughan, C. A., Handel, T. M., Mercer, A., Brunetti, C., McFadden, G., Fleming, S. B. (2003). Analysis of an orf virus chemokine-binding protein: Shifting ligand specificities among a family of poxvirus viroceptors. Proc. Natl. Acad. Sci. USA 100: 15137-15142 [Abstract] [Full Text]  
• Reading, P. C., Smith, G. L. (2003). Vaccinia Virus Interleukin-18-Binding Protein Promotes Virulence by Reducing Gamma Interferon Production and Natural Killer and T-Cell Activity. J. Virol. 77: 9960-9968 [Abstract] [Full Text]  
• Ribas, G., Rivera, J., Saraiva, M., Campbell, R. D., Alcami, A. (2003). Genetic Variability of Immunomodulatory Genes in Ectromelia Virus Isolates Detected by Denaturing High-Performance Liquid Chromatography. J. Virol. 77: 10139-10146 [Abstract] [Full Text]  
• Reading, P. C., Smith, G. L. (2003). A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J. Gen. Virol. 84: 1973-1983 [Abstract] [Full Text]  
• Reading, P. C., Moore, J. B., Smith, G. L. (2003). Steroid Hormone Synthesis by Vaccinia Virus Suppresses the Inflammatory Response to Infection. J. Exp. Med. 197: 1269-1278 [Abstract] [Full Text]  
• Puehler, F., Schwarz, H., Waidner, B., Kalinowski, J., Kaspers, B., Bereswill, S., Staeheli, P. (2003). An Interferon-gamma -binding Protein of Novel Structure Encoded by the Fowlpox Virus. J. Biol. Chem. 278: 6905-6911 [Abstract] [Full Text]  
• Reading, P. C., Symons, J. A., Smith, G. L. (2003). A Soluble Chemokine-Binding Protein from Vaccinia Virus Reduces Virus Virulence and the Inflammatory Response to Infection. J. Immunol. 170: 1435-1442 [Abstract] [Full Text]  
• Symons, J. A., Adams, E., Tscharke, D. C., Reading, P. C., Waldmann, H., Smith, G. L. (2002). The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model. J. Gen. Virol. 83: 2833-2844 [Abstract] [Full Text]  
• Symons, J. A., Tscharke, D. C., Price, N., Smith, G. L. (2002). A study of the vaccinia virus interferon-{gamma} receptor and its contribution to virus virulence. J. Gen. Virol. 83: 1953-1964 [Abstract] [Full Text]  
• Bartlett, N., Symons, J. A., Tscharke, D. C., Smith, G. L. (2002). The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J. Gen. Virol. 83: 1965-1976 [Abstract] [Full Text]  
• Tscharke, D. C., Reading, P. C., Smith, G. L. (2002). Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J. Gen. Virol. 83: 1977-1986 [Abstract] [Full Text]  
• Panus, J. F., Smith, C. A., Ray, C. A., Smith, T. D., Patel, D. D., Pickup, D. J. (2002). Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: A soluble, secreted CD30 homologue. Proc. Natl. Acad. Sci. USA 99: 8348-8353 [Abstract] [Full Text]  
• Gubser, C., Smith, G. L. (2002). The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox. J. Gen. Virol. 83: 855-872 [Abstract] [Full Text]  
• Price, N., Tscharke, D. C., Smith, G. L. (2002). The vaccinia virus B9R protein is a 6 kDa intracellular protein that is non-essential for virus replication and virulence. J. Gen. Virol. 83: 873-878 [Abstract] [Full Text]  
• Alcami, A., Smith, G. L. (2002). The vaccinia virus soluble interferon-{gamma} receptor is a homodimer. J. Gen. Virol. 83: 545-549 [Abstract] [Full Text]  
• Smith, V. P., Alcami, A. (2002). Inhibition of Interferons by Ectromelia Virus. J. Virol. 76: 1124-1134 [Abstract] [Full Text]  
• Gardner, J. D., Tscharke, D. C., Reading, P. C., Smith, G. L. (2001). Vaccinia virus semaphorin A39R is a 50-55 kDa secreted glycoprotein that affects the outcome of infection in a murine intradermal model. J. Gen. Virol. 82: 2083-2093 [Abstract] [Full Text]  
• Ng, A., Tscharke, D. C., Reading, P. C., Smith, G. L. (2001). The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence. J. Gen. Virol. 82: 2095-2105 [Abstract] [Full Text]  
• Johnson, T. R., Fischer, J. E., Graham, B. S. (2001). Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine. J. Gen. Virol. 82: 2107-2116 [Abstract] [Full Text]  
• Hallermalm, K., Seki, K., Wei, C., Castelli, C., Rivoltini, L., Kiessling, R., Levitskaya, J. (2001). Tumor necrosis factor-{alpha} induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface. Blood 98: 1108-1115 [Abstract] [Full Text]  
• Almazan, F., Tscharke, D. C., Smith, G. L. (2001). The Vaccinia Virus Superoxide Dismutase-Like Protein (A45R) Is a Virion Component That Is Nonessential for Virus Replication. J. Virol. 75: 7018-7029 [Abstract] [Full Text]  
• Najarro, P., Traktman, P., Lewis, J. A. (2001). Vaccinia Virus Blocks Gamma Interferon Signal Transduction: Viral VH1 Phosphatase Reverses Stat1 Activation. J. Virol. 75: 3185-3196 [Abstract] [Full Text]  
• Verardi, P. H., Jones, L. A., Aziz, F. H., Ahmad, S., Yilma, T. D. (2001). Vaccinia Virus Vectors with an Inactivated Gamma Interferon Receptor Homolog Gene (B8R) Are Attenuated In Vivo without a Concomitant Reduction in Immunogenicity. J. Virol. 75: 11-18 [Abstract] [Full Text]  
• Saraiva, M., Alcami, A. (2001). CrmE, a Novel Soluble Tumor Necrosis Factor Receptor Encoded by Poxviruses. J. Virol. 75: 226-233 [Abstract] [Full Text]  
• Alcamí, A., Symons, J. A., Smith, G. L. (2000). The Vaccinia Virus Soluble Alpha/Beta Interferon (IFN) Receptor Binds to the Cell Surface and Protects Cells from the Antiviral Effects of IFN. J. Virol. 74: 11230-11239 [Abstract] [Full Text]  
• Goodbourn, S., Didcock, L., Randall, R. E. (2000). Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81: 2341-2364 [Full Text]  
• Deane, D., McInnes, C. J., Percival, A., Wood, A., Thomson, J., Lear, A., Gilray, J., Fleming, S., Mercer, A., Haig, D. (2000). Orf Virus Encodes a Novel Secreted Protein Inhibitor of Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2. J. Virol. 74: 1313-1320 [Abstract] [Full Text]  
• Xiang, Y., Moss, B. (1999). IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. Proc. Natl. Acad. Sci. USA 96: 11537-11542 [Abstract] [Full Text]  
• Turner, P. C., Sancho, M. C., Thoennes, S. R., Caputo, A., Bleackley, R. C., Moyer, R. W. (1999). Myxoma Virus Serp2 Is a Weak Inhibitor of Granzyme B and Interleukin-1beta -Converting Enzyme In Vitro and Unlike CrmA Cannot Block Apoptosis in Cowpox Virus-Infected Cells. J. Virol. 73: 6394-6404 [Abstract] [Full Text]  
• Wilcock, D., Duncan, S. A., Traktman, P., Zhang, W.-H., Smith, G. L. (1999). The vaccinia virus A40R gene product is a nonstructural, type II membrane glycoprotein that is expressed at the cell surface. J. Gen. Virol. 80: 2137-2148 [Abstract] [Full Text]  
• Alcami, A, Khanna, A, Paul, N., Smith, G. (1999). Vaccinia virus strains Lister, USSR and Evans express soluble and cell- surface tumour necrosis factor receptors. J. Gen. Virol. 80: 949-959 [Abstract]  
• Mahalingam, S., Farber, J. M., Karupiah, G. (1999). The Interferon-Inducible Chemokines MuMig and Crg-2 Exhibit Antiviral Activity In Vivo. J. Virol. 73: 1479-1491 [Abstract] [Full Text]  
• Messud-Petit, F., Gelfi, J., Delverdier, M., Amardeilh, M.-F., Py, R., Sutter, G., Bertagnoli, S. (1998). Serp2, an Inhibitor of the Interleukin-1beta -Converting Enzyme, Is Critical in the Pathobiology of Myxoma Virus. J. Virol. 72: 7830-7839 [Abstract] [Full Text]  
• Laidlaw, S. M., Anwar, M. A., Thomas, W., Green, P., Shaw, K., Skinner, M. A. (1998). Fowlpox Virus Encodes Nonessential Homologs of Cellular Alpha-SNAP, PC-1, and an Orphan Human Homolog of a Secreted Nematode Protein. J. Virol. 72: 6742-6751 [Abstract] [Full Text]  
• Cavanaugh, V. J., Guidotti, L. G., Chisari, F. V. (1998). Inhibition of Hepatitis B Virus Replication during Adenovirus and Cytomegalovirus Infections in Transgenic Mice. J. Virol. 72: 2630-2637 [Abstract] [Full Text]  
• Weihua, X., Ramanujam, S., Lindner, D. J., Kudaravalli, R. D., Freund, R., Kalvakolanu, D. V. (1998). The polyoma virus T antigen interferes with interferon-inducible gene expression. Proc. Natl. Acad. Sci. USA 95: 1085-1090 [Abstract] [Full Text]  
• Alcami, A., Symons, J. A., Collins, P. D., Williams, T. J., Smith, G. L. (1998). Blockade of Chemokine Activity by a Soluble Chemokine Binding Protein from Vaccinia Virus. J. Immunol. 160: 624-633 [Abstract] [Full Text]  
• Schreiber, M., Rajarathnam, K., McFadden, G. (1996). Myxoma Virus T2 Protein, a Tumor Necrosis Factor (TNF) Receptor Homolog, Is Secreted as a Monomer and Dimer That Each Bind Rabbit TNFalpha , but the Dimer Is a More Potent TNF Inhibitor. J. Biol. Chem. 271: 13333-13341 [Abstract] [Full Text]